» Articles » PMID: 37123415

The Proteasome: A Key Modulator of Nervous System Function, Brain Aging, and Neurodegenerative Disease

Overview
Specialty Cell Biology
Date 2023 May 1
PMID 37123415
Authors
Affiliations
Soon will be listed here.
Abstract

The proteasome is a large multi-subunit protease responsible for the degradation and removal of oxidized, misfolded, and polyubiquitinated proteins. The proteasome plays critical roles in nervous system processes. This includes maintenance of cellular homeostasis in neurons. It also includes roles in long-term potentiation via modulation of CREB signaling. The proteasome also possesses roles in promoting dendritic spine growth driven by proteasome localization to the dendritic spines in an NMDA/CaMKIIα dependent manner. Proteasome inhibition experiments in varied organisms has been shown to impact memory, consolidation, recollection and extinction. The proteasome has been further shown to impact circadian rhythm through modulation of a range of 'clock' genes, and glial function. Proteasome function is impaired as a consequence both of aging and neurodegenerative diseases. Many studies have demonstrated an impairment in 26S proteasome function in the brain and other tissues as a consequence of age, driven by a disassembly of 26S proteasome in favor of 20S proteasome. Some studies also show proteasome augmentation to correct age-related deficits. In amyotrophic lateral sclerosis Alzheimer's, Parkinson's and Huntington's disease proteasome function is impaired through distinct mechanisms with impacts on disease susceptibility and progression. Age and neurodegenerative-related deficits in the function of the constitutive proteasome are often also accompanied by an increase in an alternative form of proteasome called the immunoproteasome. This article discusses the critical role of the proteasome in the nervous system. We then describe how proteasome dysfunction contributes to brain aging and neurodegenerative disease.

Citing Articles

Posterior cingulate cortex microRNA dysregulation differentiates cognitive resilience, mild cognitive impairment, and Alzheimer's disease.

Counts S, Beck J, Maloney B, Malek-Ahmadi M, Ginsberg S, Mufson E Alzheimers Dement. 2025; 21(2):e70019.

PMID: 40008917 PMC: 11863362. DOI: 10.1002/alz.70019.


Mechanisms of ubiquitin-independent proteasomal degradation and their roles in age-related neurodegenerative disease.

Church T, Margolis S Front Cell Dev Biol. 2025; 12:1531797.

PMID: 39990094 PMC: 11842346. DOI: 10.3389/fcell.2024.1531797.


Proteasome Augmentation Mitigates Age-Related Cognitive Decline in Mice.

Parker D, Davidson K, Osmulski P, Gaczynska M, Pickering A Aging Cell. 2025; 24(3):e14492.

PMID: 39945352 PMC: 11896255. DOI: 10.1111/acel.14492.


Plasma Proteome Alterations of Laying Hens Subjected to Heat Stress and Fed a Diet Supplemented with Pequi Oil (): New Insights in the Identification of Heat Stress Biomarkers.

da Silva J, Andrade L, Rodrigues P, Cordeiro L, Lima G, Lopes J Biomolecules. 2024; 14(11).

PMID: 39595600 PMC: 11591700. DOI: 10.3390/biom14111424.


Structural Analysis of the 20S Proteasome Using Native Mass Spectrometry and Ultraviolet Photodissociation.

Walker J, Gautam A, Matouschek A, Brodbelt J J Proteome Res. 2024; 23(12):5438-5448.

PMID: 39475212 PMC: 11660092. DOI: 10.1021/acs.jproteome.4c00568.


References
1.
Wang X, Li S, Chou A, Bronstein J . Inhibitory effects of pesticides on proteasome activity: implication in Parkinson's disease. Neurobiol Dis. 2006; 23(1):198-205. DOI: 10.1016/j.nbd.2006.02.012. View

2.
Ciechanover A, Orian A, Schwartz A . The ubiquitin-mediated proteolytic pathway: mode of action and clinical implications. J Cell Biochem Suppl. 2000; 34:40-51. DOI: 10.1002/(sici)1097-4644(2000)77:34+<40::aid-jcb9>3.0.co;2-6. View

3.
Hamilton A, Lambert J, Parajuli L, Vivas O, Park D, Stein I . A dual role for the RhoGEF Ephexin5 in regulation of dendritic spine outgrowth. Mol Cell Neurosci. 2017; 80:66-74. PMC: 5526822. DOI: 10.1016/j.mcn.2017.02.001. View

4.
Tracz M, Bialek W . Beyond K48 and K63: non-canonical protein ubiquitination. Cell Mol Biol Lett. 2021; 26(1):1. PMC: 7786512. DOI: 10.1186/s11658-020-00245-6. View

5.
Eide E, Woolf M, Kang H, Woolf P, Hurst W, Camacho F . Control of mammalian circadian rhythm by CKIepsilon-regulated proteasome-mediated PER2 degradation. Mol Cell Biol. 2005; 25(7):2795-807. PMC: 1061645. DOI: 10.1128/MCB.25.7.2795-2807.2005. View